EUDA Health Holdings Ltd

EUDA Health Holdings Limited operates primarily as a healthcare services provider offering non-invasive treatment options and wellness products across Singapore, Malaysia, and China. The company's core healthcare offerings include bioenergy capsule treatments, stem cell therapy, and CRISPR gene editing services, alongside a line of health supplements. These services represent the company's primary focus within the healthcare sector, targeting patients seeking alternative and advanced therapeutic approaches.

Beyond its healthcare operations, EUDA maintains a secondary business segment in property management services. The combination of healthcare services and property management reflects a diversified revenue model, though healthcare services comprise the primary business focus. The company maintains its headquarters in Singapore with approximately 117 full-time employees distributed across its operating markets in Southeast Asia and China. As a Nasdaq-listed entity incorporated in the British Virgin Islands, EUDA operates as a relatively small-scale enterprise with a geographically distributed presence across multiple Asian markets.